Find Clinical Trials & Studies
E2023-A001-304
I'm Interested!
A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Study With Open-Label Extension Phase of Lorcaserin as Adjunctive Treatment in Subjects With Dravet Syndrome
- Sex at Birth: Any
- Age: Child (Birth - 17), Adult (18 - 64), Older Adult (65+)
- Accepting Healthy People: No
- Type: Interventional / Therapeutic
- Trial Phase: Phase III
- Conditions Being Studied: Epilepsy
Study Purpose
The purpose of this study is to assess the safety (symptoms and medical problems you may experience –known as side effects) and efficacy (how well and for how long the study drug treated) of the study drug on subjects who have Dravet syndrome.
Who Can Participate
Age: 2 years and older
Locations
UH Cleveland Medical Center
11100 Euclid Avenue
Cleveland OH, 44106
- UH IRB: STUDY20210262
- StudyID: 2021-0530
- ClinicalTrials.gov: NCT04572243
I'm Interested!
Questions or concerns? We're here to help.
Non-cancer Trials: 1-833-78TRIAL or Contact Us Online
Cancer Trials: 1-800-641-2422